Table of contents

Electronic pages

• Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" (20 April, 2023)

  Maarten Boers
• Response to: Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" by Boers (20 April, 2023)

  Paul Studenic, Daniel Aletaha, Tanja A Stamm, Maarten de Wit, Diane Lacaille, Josef S Smolen, David Felson
• Correspondence on “Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis” (20 May, 2022)

  Jean Roudier
• Response to: Correspondence on “HLA-DR ‘naturally’ presented peptides: you will find what you have pulsed with” by Roudier (20 May, 2022)

  Diego Catalan, Dolores Jaraquemada, Juan C Aguillón
• Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" (3 February, 2023)

  Juergen Braun
• Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Braun et al

  (6 March, 2023)

  Sofia Ramiro, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert BM Landewé, Désirée van der Heijde
• Correspondence on ‘Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7’ (15 June, 2022)

  Richard F Loeser, Philip R Coryell
• Response to: Correspondence on ‘Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7’ by Loeser et al

  (15 June, 2022)

  Haiyan Zhang, Daozhang Cai, Xiaochun Bai
• Correspondence on ‘2018 update of the EULAR recommendations for the management of hand osteoarthritis’ (20 October, 2020)

  Young Sun Suh, Hyun-Ok Kim, Chang Han Lee, Chul Ho Yoon, Yun-Hong Cheon, Mingyo Kim, Hanna Lee, Sang-Il Lee
• Correspondence on ‘The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease’ (4 November, 2020)

  Rory James Redmond Peters, Harry Martin, Aleena Virdee, Eve Fryer, Helen Bungay, Manuel Rodriguez-Justo, Manil Chouhan, Eleanor Barnes, George Webster, Emma L Culver
• COVID-19 in Italian patients with rheumatic autoimmune systemic diseases (14 October, 2020)

  Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Poupak Fallahi, Alessandro Antonelli
• Correspondence on ‘The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series’ (3 November, 2020)

  Ryu Watanabe, Motomu Hashimoto, Akio Morinobu
• Correction: Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

  (3 July, 2023)